admin.veranex

Study by Veranex and Thermo Fisher Highlights Payer Budget Impact of Novel Test for Kidney Transplant Rejection

By developing a U.S. payer budget impact model and associated manuscript for Thermo Fisher’s Molecular Microscope® MMDx®-Kidney (a microarray with machine learning for kidney biopsy interpretation), Veranex supported Thermo Fisher’s efforts to...

Read More

Dasiglucagon Demonstrates Reduced Costs in the Treatment of Severe Hypoglycemia in a Budget Impact Model

Jordan Hinahara and Thomas Goss, members of our Commercial Strategy and Market Access team, contributed to the budget impact model. The objective was...

Read More

What differentiates us? It’s our people

Hear from Brian Loushine and why our people can create great outcomes.

Read More

Digital Healthcare:  To Discovery and Beyond

We recently sat down with Gary Keeler, Director of Digital Experiences and subject matter expert, to discuss the vast opportunities that exist in the...

Read More

Veranex Presents Study Results at the National Kidney Foundation Spring Clinical Meeting

Dr. Manasi Datar and colleagues used conjoint analysis to estimate preferences regarding kidney disease testing from 401 PCPs via a web survey....

Read More

One Minute With the Expert

We sat down with Dr. Olivier Chevènement, DVM, PhD, Veterinary Surgeon and Study Director at Veranex to discuss comparative anatomy of the tricuspid...

Read More

Product Design and Engineering Sales Sheet

Fullscreen Mode

Read More

Digital Health Innovation Summit

Genice Gallegos is a confirmed speaker/panelist at the Digital Health Innovation Summit and will be speaking during Day 2 on the important panel...

Read More